160 related articles for article (PubMed ID: 26098128)
1. Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD.
Farnia V; Hojatitabar S; Shakeri J; Rezaei M; Yazdchi K; Bajoghli H; Holsboer-Trachsler E; Brand S
Pharmacopsychiatry; 2015 Jul; 48(4-5):156-63. PubMed ID: 26098128
[TBL] [Abstract][Full Text] [Related]
2. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.
Farnia V; Shirzadifar M; Shakeri J; Rezaei M; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2015; 11():625-35. PubMed ID: 25834441
[TBL] [Abstract][Full Text] [Related]
3. Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial.
Farnia V; Tatari F; Alikhani M; Shakeri J; Taghizadeh M; Karbasizadeh H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
Drug Alcohol Depend; 2017 Jul; 176():117-125. PubMed ID: 28531768
[TBL] [Abstract][Full Text] [Related]
4. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.
Safarinejad MR
J Psychopharmacol; 2011 Mar; 25(3):370-8. PubMed ID: 20080928
[TBL] [Abstract][Full Text] [Related]
5. Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial.
Shahmoradi N; Davarinejad O; Brühl AB; Brand S
Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763782
[No Abstract] [Full Text] [Related]
6. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
7. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study.
Safarinejad MR
BJU Int; 2010 Sep; 106(6):840-7. PubMed ID: 20067456
[TBL] [Abstract][Full Text] [Related]
8. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
Landén M; Eriksson E; Agren H; Fahlén T
J Clin Psychopharmacol; 1999 Jun; 19(3):268-71. PubMed ID: 10350034
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.
DeBattista C; Solvason B; Poirier J; Kendrick E; Loraas E
J Clin Psychiatry; 2005 Jul; 66(7):844-8. PubMed ID: 16013899
[TBL] [Abstract][Full Text] [Related]
10. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
11. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.
Masiran R; Sidi H; Mohamed Z; Mohamed Saini S; Nik Jaafar NR
Asia Pac Psychiatry; 2013 Apr; 5 Suppl 1():41-9. PubMed ID: 23857836
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study.
van Rooij K; Poels S; Worst P; Bloemers J; Koppeschaar H; Goldstein A; Olivier B; Tuiten A
Eur J Pharmacol; 2015 Apr; 753():246-51. PubMed ID: 25460030
[TBL] [Abstract][Full Text] [Related]
13. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
Landén M; Högberg P; Thase ME
J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
[TBL] [Abstract][Full Text] [Related]
14. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
15. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
Clayton A; Kornstein S; Prakash A; Mallinckrodt C; Wohlreich M
J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
[TBL] [Abstract][Full Text] [Related]
16. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
[TBL] [Abstract][Full Text] [Related]
17. SSRI sexual dysfunction: a female perspective.
Hensley PL; Nurnberg HG
J Sex Marital Ther; 2002; 28 Suppl 1():143-53. PubMed ID: 11898696
[TBL] [Abstract][Full Text] [Related]
18. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.
Clayton AH; McGarvey EL; Abouesh AI; Pinkerton RC
J Clin Psychiatry; 2001 Mar; 62(3):185-90. PubMed ID: 11305705
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial.
Khazaie H; Rezaie L; Rezaei Payam N; Najafi F
Gen Hosp Psychiatry; 2015; 37(1):40-5. PubMed ID: 25467077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
